We comply with the HONcode standard for trustworthy health information - verify here. If your dose is different, do not change it unless your doctor tells you to do so. Zolpidem images Zolpidem Tartrate 10mg Tablet This medicine is a white, round tablet imprinted with "54 ". Generic zolpidem is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. There are other drugs available to treat your condition. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. It is more popular than comparable drugs.
This is a drug discount program, not an insurance plan. Zolpidem offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office. There are currently no Manufacturer Promotions that we know about for this drug. Patient assistance programs PAPs are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines.
Eligibility requirements vary for each program. There are currently no Patient Assistance Programs that we know about for this drug. Insomnia melatonin , lorazepam , amitriptyline , Ambien , Ativan , diphenhydramine , temazepam , doxepin , Elavil , Restoril , Lunesta , Ibuprofen PM , eszopiclone , Belsomra , Rozerem , triazolam , zaleplon , ramelteon , Sonata , doxylamine , Halcion , Silenor , flurazepam , estazolam , More The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records.
Available for Android and iOS devices. Subscribe to receive email notifications whenever new articles are published. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. To view content sources and attributions, please refer to our editorial policy. We comply with the HONcode standard for trustworthy health information - verify here. Ask your pharmacist for your discount price.
The clinical trials performed in support of efficacy were weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Observed reactions include anaphylaxis and angioedema. The recommended dose for adults is 10 mg once daily immediately before bedtime. Patients with hepatic insufficiency do not clear the drug as rapidly as normal subjects.
These discounts are then passed directly on to cardholders. Unlike insurance programs, there is no income, age, pre-existing condition, deductible, or waiting period restrictions. There are no premiums or deductibles associated with this program whatsoever. While pharmacy prices may vary from week-to-week and by the geographic location, the patient is guaranteed the lowest price available regardless of whether it is the ZolpidemDiscount.
Worsening of insomnia or the emergence of new thinking or behavior abnormalities may be the consequence of an unrecognized psychiatric or physical disorder. Rare cases of angioedema involving the tongue, glottis or larynx have been reported in patients after taking the first or subsequent doses of sedative-hypnotics, including ZOLPIDEM. Some patients have had additional symptoms such as dyspnea, throat closing or nausea and vomiting that suggest anaphylaxis. Some patients have required medical therapy in the emergency department.
If angioedema involves the throat, glottis or larynx, airway obstruction may occur and be fatal. Some of these changes may be characterized by decreased inhibition e. Visual and auditory hallucinations have been reported as well as behavioral changes such as bizarre behavior, agitation and depersonalization. In a clinical trial, 7. These events can occur in sedative-hypnotic-naive as well as in sedative-hypnotic-experienced persons.
Other complex behaviors e. Amnesia, anxiety and other neuro-psychiatric symptoms may occur unpredictably. It can rarely be determined with certainty whether a particular instance of the abnormal behaviors listed above is drug induced, spontaneous in origin, or a result of an underlying psychiatric or physical disorder. Nonetheless, the emergence of any new behavioral sign or symptom of concern requires careful and immediate evaluation.
Patients should be cautioned against engaging in hazardous occupations requiring complete mental alertness or motor coordination such as operating machinery or driving a motor vehicle after ingesting the drug, including potential impairment of the performance of such activities that may occur the day following ingestion of ZOLPIDEM tartrate. Patients should also be cautioned about possible combined effects with other CNS-depressant drugs.
These patients should be closely monitored. Post-marketing reports of respiratory insufficiency, most of which involved patients with pre-existing respiratory impairment, have been received. Data in end-stage renal failure patients repeatedly treated with ZOLPIDEM tartrate did not demonstrate drug accumulation or alterations in pharmacokinetic parameters. No dosage adjustment in renally impaired patients is required; however, these patients should be closely monitored.
A study in subjects with hepatic impairment did reveal prolonged elimination in this group; therefore, treatment should be initiated with 5 mg in patients with hepatic compromise, and they should be closely monitored. Suicidal tendencies may be present in such patients and protective measures may be required. Intentional over-dosage is more common in this group of patients; therefore, the least amount of drug that is feasible should be prescribed for the patient at any one time.
Hallucinations were reported in 7. Interference with laboratory tests: In addition, clinical data indicate that ZOLPIDEM does not cross-react with benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screens. Call your doctor for medical advice about side effects. Abuse and addiction are separate and distinct from physical dependence and tolerance. Abuse is characterized by misuse of the drug for non-medical purposes, often in combination with other psychoactive substances.
Tolerance is a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug effects over time. Tolerance may occur to both desired and undesired effects of drugs and may develop at different rates for different effects. Addiction is a primary, chronic, neurobiological disease with genetic, psychosocial, and environmental factors influencing its development and manifestations.
It is characterized by behaviors that include one or more of the following: Drug addiction is a treatable disease, using a multidisciplinary approach, but relapse is common.